While obtaining human serum samples for the testing of ovarian cancer, to avoid the presence of other biomarkers like CEA and CA-15-3, along with CA-125, each serum sample is placed on a plate covered with an antibody specific to CA-125. This evidence concerns the gene MUC16 and ovarian carcinoma.